Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,837,566
in 4 filings, $626K under 10b5-1 plans

Net −$1,837,566. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 78 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-12-05 Kelbon Marcia S. VP Patent and General Counsel Grant or award · Stock Option (Right to Buy) +80,000 80,000
2016-12-05 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +102,040 $0.98 $100K 1,987,025
2016-12-05 Demopulos Gregory A MD Chairman, CEO & President Sale −102,040 $10.71 $1.1M 1,884,985
2016-12-05 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −102,040 204,084
2016-12-05 Demopulos Gregory A MD Chairman, CEO & President Grant or award · Stock Option (Right to Buy) +400,000 400,000
2016-12-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +102,040 $0.98 $100K 1,805,862
2016-12-02 Demopulos Gregory A MD Chairman, CEO & President Sale −102,040 $11.00 $1.1M 1,703,822
2016-12-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +181,163 $0.98 $178K 1,884,985
2016-12-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −102,040 306,124
2016-12-02 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −181,163 0
2016-12-01 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +106,521 $0.98 $104K 1,810,343
2016-12-01 Demopulos Gregory A MD Chairman, CEO & President Sale −105,522 $11.56 $1.2M 1,704,821
2016-12-01 Demopulos Gregory A MD Chairman, CEO & President Sale −999 $12.32 $12K 1,703,822
2016-12-01 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −106,521 408,164
2016-11-30 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion +97,559 $0.98 $96K 1,801,381
2016-11-30 Demopulos Gregory A MD Chairman, CEO & President Sale −97,559 $12.21 $1.2M 1,703,822
2016-11-30 Demopulos Gregory A MD Chairman, CEO & President Exercise or conversion · Stock Option (Right to Buy) −97,559 514,685
2016-10-12 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +3,004 $6.05 $18K 166,601
2016-10-12 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion · Stock Option (Right to Buy) −3,004 13,040
2016-09-15 Kelbon Marcia S. VP Patent and General Counsel Exercise or conversion +16,000 $0.98 $16K 179,597

Page 16 of 20 · 391 trades